Puneet Souda
Stock Analyst at SVB Leerink
(1.89)
# 1,731
Out of 4,414 analysts
175
Total ratings
43.78%
Success rate
-2.63%
Average return
Main Sectors:
25 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $16.81 | -40.51% | 5 | Jul 13, 2023 | |
| TMO Thermo Fisher | Maintains: Outperform | $630 | $574.99 | +9.57% | 17 | Jul 6, 2023 | |
| CSTL Castle Biosciences | Maintains: Outperform | $50 → $35 | $22.02 | +58.95% | 7 | Jun 5, 2023 | |
| A Agilent Technologies | Maintains: Outperform | $170 → $145 | $138.69 | +4.55% | 18 | May 24, 2023 | |
| WAT Waters | Maintains: Market Perform | $300 | $315.92 | -5.04% | 13 | May 9, 2023 | |
| DHR Danaher | Initiates: Outperform | $300 | $246.89 | +21.51% | 1 | May 1, 2023 | |
| ILMN Illumina | Maintains: Outperform | $249 → $250 | $124.68 | +100.51% | 13 | Feb 8, 2023 | |
| TECH Bio-Techne | Maintains: Outperform | $125 → $110 | $73.46 | +49.74% | 6 | Feb 3, 2023 | |
| HOLX Hologic | Maintains: Outperform | $90 → $93 | $76.28 | +21.92% | 5 | Feb 2, 2023 | |
| EXAS Exact Sciences | Maintains: Outperform | $70 → $75 | $60.01 | +24.98% | 16 | Jan 12, 2023 | |
| RGEN Repligen | Maintains: Outperform | $230 → $200 | $158.36 | +26.29% | 7 | Jan 6, 2023 | |
| MASS 908 Devices | Maintains: Outperform | $25 → $20 | $5.68 | +252.11% | 5 | Jan 6, 2023 | |
| ABCL AbCellera Biologics | Maintains: Outperform | $20 → $18 | $3.78 | +376.19% | 6 | Jan 6, 2023 | |
| OABI OmniAb | Initiates: Outperform | $6 | $4.56 | +31.58% | 1 | Nov 29, 2022 | |
| TWST Twist Bioscience | Maintains: Market Perform | $45 → $30 | $31.96 | -6.13% | 6 | Nov 21, 2022 | |
| OLK Olink Holding AB (publ) | Maintains: Outperform | $25 → $27 | $22.68 | +19.05% | 4 | Nov 15, 2022 | |
| QTRX Quanterix | Maintains: Market Perform | $12 → $15 | $16.49 | -9.04% | 7 | Nov 9, 2022 | |
| NEO NeoGenomics | Maintains: Outperform | $12 → $15 | $13.96 | +7.45% | 6 | Nov 9, 2022 | |
| VCYT Veracyte | Maintains: Outperform | $30 → $35 | $20.13 | +73.87% | 9 | Nov 3, 2022 | |
| MYGN Myriad Genetics | Maintains: Market Perform | $27 → $25 | $19.47 | +28.40% | 5 | Nov 2, 2022 | |
| CNTG Centogene | Maintains: Outperform | $10 → $6 | $0.44 | +1,263.64% | 1 | Jul 18, 2022 | |
| BRKR Bruker | Maintains: Outperform | $85 → $87 | $79.03 | +10.08% | 6 | May 5, 2022 | |
| GH Guardant Health | Maintains: Outperform | $170 → $140 | $18.26 | +666.70% | 3 | Feb 24, 2022 | |
| NTRA Natera | Maintains: Outperform | n/a | $94.15 | - | 3 | Jun 22, 2021 | |
| TTOO T2 Biosystems | Maintains: Outperform | $20,000 → $15,000 | $3.00 | +499,900.00% | 5 | Jan 27, 2021 |
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $16.81
Upside: -40.51%
Thermo Fisher
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $574.99
Upside: +9.57%
Castle Biosciences
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $22.02
Upside: +58.95%
Agilent Technologies
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $138.69
Upside: +4.55%
Waters
May 9, 2023
Maintains: Market Perform
Price Target: $300
Current: $315.92
Upside: -5.04%
Danaher
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $246.89
Upside: +21.51%
Illumina
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $124.68
Upside: +100.51%
Bio-Techne
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $73.46
Upside: +49.74%
Hologic
Feb 2, 2023
Maintains: Outperform
Price Target: $90 → $93
Current: $76.28
Upside: +21.92%
Exact Sciences
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $60.01
Upside: +24.98%
Repligen
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $158.36
Upside: +26.29%
908 Devices
Jan 6, 2023
Maintains: Outperform
Price Target: $25 → $20
Current: $5.68
Upside: +252.11%
AbCellera Biologics
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $3.78
Upside: +376.19%
OmniAb
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $4.56
Upside: +31.58%
Twist Bioscience
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $31.96
Upside: -6.13%
Olink Holding AB (publ)
Nov 15, 2022
Maintains: Outperform
Price Target: $25 → $27
Current: $22.68
Upside: +19.05%
Quanterix
Nov 9, 2022
Maintains: Market Perform
Price Target: $12 → $15
Current: $16.49
Upside: -9.04%
NeoGenomics
Nov 9, 2022
Maintains: Outperform
Price Target: $12 → $15
Current: $13.96
Upside: +7.45%
Veracyte
Nov 3, 2022
Maintains: Outperform
Price Target: $30 → $35
Current: $20.13
Upside: +73.87%
Myriad Genetics
Nov 2, 2022
Maintains: Market Perform
Price Target: $27 → $25
Current: $19.47
Upside: +28.40%
Centogene
Jul 18, 2022
Maintains: Outperform
Price Target: $10 → $6
Current: $0.44
Upside: +1,263.64%
Bruker
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $79.03
Upside: +10.08%
Guardant Health
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $18.26
Upside: +666.70%
Natera
Jun 22, 2021
Maintains: Outperform
Price Target: n/a
Current: $94.15
Upside: -
T2 Biosystems
Jan 27, 2021
Maintains: Outperform
Price Target: $20,000 → $15,000
Current: $3.00
Upside: +499,900.00%